Screener
Royalty Pharma RPRX Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Royalty Pharma’s reported figures.
Based on trailing twelve months.
The source filing: Royalty Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 9:02 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001802768-26-000015
FAQ
- What is Royalty Pharma's net margin?
- Royalty Pharma (RPRX) reported net margin of 32.1% in Q2 2026.
- How has Royalty Pharma's net margin changed year-over-year?
- Royalty Pharma's net margin decreased by 27.6% year-over-year, from 44.4% to 32.1%.
- What is the long-term trend for Royalty Pharma's net margin?
- Over 4 years (2020 to 2025), Royalty Pharma's net margin has grown at a -22.2% compound annual growth rate (CAGR), from 88.6% to 32.5%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Royalty Pharma's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude